Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
RESEARCH TOOLSreports
Holding SONN?
Track your performance easily
Sonnet BioTherapeutics Holdings (SONN) Ownership Overview
The ownership structure of Sonnet BioTherapeutics Holdings (SONN) stock is a mix of institutional, retail, and individual investors. , 6.50% is owned by Insiders, and 93.06% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 198,300 | Insider | 6.50% | 509,631 | |
| 1,840 | Institution | 0.22% | 4,729 | |
| 1,840 | Institution | 0.22% | 4,729 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,840 | Institution | 0.22% | 4,729 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,840 | Institution | 0.22% | 8,335 |
FAQ
Who Owns Sonnet BioTherapeutics Holdings (SONN)?
Currently, no data Available
What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by institutional investors?
Currently, no data Available
What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.06% of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors.
Who owns the most shares of Sonnet BioTherapeutics Holdings (SONN)?
Markey John owns the most shares of Sonnet BioTherapeutics Holdings (SONN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.